Jardiance 10 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26FT5FX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,117
Award facts
- Contract value 100% obligated
- $27,116.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerSourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order on January 9, 2026, by the Defense Logistics Agency (DLA) for the supply of Jardiance 10 mg tablets in a 90-count configuration. This non-set-aside, competitively awarded contract carries a firm fixed price ceiling value of $27,116.89 with an ultimate completion date of January 12, 2026. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerSourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of medications and medical supplies to support military healthcare programs worldwide.
As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerSourceBergen demonstrates significant capability in fulfilling Defense Department pharmaceutical requirements across multiple therapeutic domains. The DLA Medical Supply Chain utilizes AmerSourceBergen's extensive distribution network and product portfolio to support military treatment facilities and defense health system operations. This particular delivery order for Jardiance, a diabetes medication, represents one of many task orders executed under the parent IDC vehicle and reflects the company's ongoing role in supplying essential pharmaceutical commodities to federal healthcare beneficiaries, including active duty service members, veterans, and other eligible populations served through the Defense Health Agency.
Quick answers
Who was awarded contract SPE2DR26FT5FX?
SPE2DR26FT5FX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26FT5FX worth?
The government has obligated $27,117 on SPE2DR26FT5FX.
Is contract SPE2DR26FT5FX an order under another contract?
Yes. SPE2DR26FT5FX is a delivery order under SPE2DR25D3201, an indefinite delivery contract.
Was contract SPE2DR26FT5FX competed?
The extent of competition for SPE2DR26FT5FX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award